Surgical Robotics Innovation Development Forum | Industry Giants Lead the Way, Policy Support Accelerates – Has the Tipping Point for Surgical Robots Arrived?
The global surgical robot market exceeds $10 billion, with the Chinese market demonstrating strong upward explosive potential.
As an innovative intelligent medical device, the surgical robot can perform delicate surgical procedures within body cavities, blood vessels, and nerve-dense regions. It offers advantages such as precise positioning, minimal surgical trauma, reduced risk of infection, and accelerated postoperative recovery. By meeting patients’ demand for high-quality medical services and helping to better address global shortages of medical resources, it has attracted widespread attention worldwide.
China has a large patient population, resulting in a substantial volume of minimally invasive surgeries requiring surgical robots. Relevant data show that investment and financing in China’s surgical robot industry accelerated significantly in 2021, with the number of deals rising from one in 2013 to 27 for the full year, reaching 29 in 2022; total financing across the sector exceeded RMB 3 billion. Although Chinese-made surgical robots are latecomers, their market size remains significantly smaller than those in the United States and the European Union. Currently, domestic companies need more time to explore areas such as supporting consumables, regulatory compliance and patents, accumulation of clinical cases, ecosystem development, and large-scale commercialization.
To address the industry development of surgical robots, the 7th Future Healthcare 100 Conference is hosted by VCBeat and supported by CDH VGC.Surgical Robot Innovation and Development Forum，Focusing on key areas of surgical robotics, including vascular intervention, endoscopic surgery, and orthopedics, this initiative integrates efforts from industry, academia, research, and clinical practice to jointly explore the opportunities and pain points of Chinese-made surgical robots in practical applications.
I.Forum Highlights:
(I)Clinical Practice: A New Milestone in the Clinical Application of Domestically Produced Surgical Robots
The innovative translation of high-end medical equipment is a crucial component of the independent development of China's medical device industry. As a key category of medical equipment, surgical robot systems have been repeatedly highlighted in China’s 14th Five-Year Plan for the Development of the Medical Equipment Industry. Breakthroughs in system development, original research and development, and the promotion of clinical applications of domestically produced surgical robot systems have attracted and motivated clinicians and engineers to actively engage in this endeavor, yielding significant achievements.To this end, the forum has specially invited renowned clinicians to share insights on the clinical application of surgical robots.
(II)Innovative Breakthrough: Full-Spectrum Layout: The Chinese Approach to Surgical Robotics
Based on different clinical scenarios, surgical robots are mainly categorized into five types: laparoscopic robots, orthopedic robots, needle-insertion robots, natural orifice transluminal endoscopic surgery (NOTES) robots, and pan-vascular robots. With industry giants paving the way and supportive policies providing further impetus, a multitude of factors have catalyzed a flourishing landscape for domestically produced surgical robots in China. This has ushered in a robust period of development with distinct Chinese characteristics, marked by the emergence of numerous outstanding enterprises. The forum has also invited innovative companies across various clinical scenarios to share in-depth insights into their technological and product innovations.
(3)Industry Blueprint: Poised for Takeoff: The Rise of Domestically Produced Surgical Robots
Surgical robots are inevitably the trend of the future, but it will take a long time before they are fully popularized. Based on the R&D and clinical trial progress of domestic enterprises, it is speculated that the market penetration rate of Chinese-made robots will be promising in the future. Although there is still a long way to go and many key technologies and details need to be addressed, this is not impossible. Perhaps the more critical question is: under the trillion-yuan blue ocean industry, where does the systemic momentum come from that companies need to think about and face? This forum will also launch a dialogue on the present and future of Chinese surgical robots.
II. ForumIntroduction
Forum Time:May 5–7, 2023
Forum Venue:Shanghai · Zhangjiang Science Hall
Forum Organizer:VB100, VCBeat, Eggshell Institute
Forum Supporting Organizations:CDH VGC
Corporate Representatives in Attendance:Tuodao Medical
※ Listed in alphabetical order by company name; rankings are not indicative of priority. More companies to be confirmed.
Forum Agenda Planning:
Discussion on the Clinical Application of Surgical Robots
The Differentiated Path of Vascular Interventional Surgical Robots: Full-Process Coverage from Diagnosis to Treatment
From Multi-Port to Single-Port: The Path to Breakthrough for Laparoscopic Surgical Robots
Exploration of Comprehensive Solutions for Orthopedic Surgery
Applications of Surgical Robots in Microsurgery
ChatGPT Ignites “AI+”: How AI Empowers the Development of Surgical Robots
The Present and Future of Domestically Produced Surgical Robots
※ Preliminary agenda topics are for reference only; the final agenda is subject to on-site confirmation.
